Startups
Edit
Euthymics Bioscience Inc
http://euthymics.com/Last activity: 19.10.2012
Active - Reference to shoppinginfarmacia.it
Overview
Employees
11-50
Total raised
$24M
Founded date
2009
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 18, 2012 | Novartis Venture Fund leads $7M round for developer of adult ADHD medication | All other existing investors joined the round, including Venture Investors, H&Q Healthcare Investors and H&Q Life Sciences Investors, GBS Venture Partners, State of Wisconsin Investment Board and Timothy Barberich, a board member of... |
| Oct 18, 2012 | Neurovance Closes $7M Series A1 Round | CAMBRIDGE, MA, Neurovance, Inc. today announced that it has closed a $7 million series A1 round led by existing investor Novartis Venture Fund. >> Click here for more funding data on Neurovance >> To export Neurovance fundin... |
| Mar 9, 2011 | Euthymics Bioscience Raised Additional $4M in Series A Financing | Euthymics Bioscience, Inc., a Cambridge, Massachusetts-based neuroscience-focused clinical-stage company developing next-generation treatments for central nervous system disorders, has raised further $4m as part of its Series A financing. T... |
| Jul 22, 2010 | Euthymics Bioscience Completes Series A Financing Totalling $24M in Milestone-Conditioned Tranches | Euthymics Bioscience, Inc., a Cambridge, Massachusetts-based clinical-stage company developing innovative antidepressants, completed a Series A financing totalling $24m in milestone-conditioned tranches. The round was led by Novartis Ventur... |
| Novartis Venture Fund leads $7M round for developer of adult ADHD medication | A Boston-area startup emerged from the depths of stealth mode today touting a $7 million financing round that will help it move toward clinical trials of a drug that would treat attention-deficit/hyperactivity disorder (ADHD) without addict... |
Reviews 0
FAQ about Euthymics Bioscience Inc
When was Euthymics Bioscience Inc founded?
Euthymics Bioscience Inc was founded in 2009.
How much funding has Euthymics Bioscience Inc raised?
Euthymics Bioscience Inc has raised $24M in total across 1 funding round.
What has the press written about Euthymics Bioscience Inc?
Parsers VC has collected 6 articles mentioning Euthymics Bioscience Inc, among them “Novartis Venture Fund leads $7M round for developer of adult ADHD medication” (Oct 18, 2012) and “Neurovance Closes $7M Series A1 Round” (Oct 18, 2012).
Is Euthymics Bioscience Inc still active?
Yes, Euthymics Bioscience Inc is active; its latest activity on Parsers VC dates from Oct 19, 2012.